AT

Birth Asphyxia & Hypoxic-Ischaemic Encephalopathy

Paediatrics · Neonatology · lean revision notes

Birth Asphyxia & Hypoxic-Ischaemic Encephalopathy

Birth asphyxia is impaired gas exchange around the time of birth leading to hypoxaemia, hypercarbia and metabolic acidosis; when this insult injures the brain, the resulting clinical syndrome is hypoxic-ischaemic encephalopathy (HIE). HIE remains a leading cause of neonatal mortality and lifelong neurodisability (cerebral palsy), and the only proven neuroprotective therapy — therapeutic hypothermia — must be started within 6 hours of birth, making early recognition a high-yield, time-critical topic.


Definitions & diagnostic criteria

"Birth asphyxia" is a clinical-pathophysiological term, not a single number. The WHO loosely defines it as failure to initiate and sustain breathing at birth. For research and medicolegal purposes, the ACOG / AAP essential criteria for an acute intrapartum hypoxic event sufficient to cause cerebral palsy are tighter and very examinable.

High-yield: A low Apgar score alone does NOT define birth asphyxia. You also need biochemical (umbilical artery acidosis) and clinical (encephalopathy) evidence.

ACOG/AAP essential criteria (all four required)

Criterion Cut-off / definition
Metabolic acidosis Umbilical arterial pH < 7.0 AND base deficit ≥ 12 mmol/L
Encephalopathy Early-onset moderate-to-severe HIE in ≥ 34 weeks neonate
Cerebral palsy type Spastic quadriplegic or dyskinetic CP
Exclusion No other identifiable cause (trauma, infection, coagulopathy, genetic/metabolic)

High-yield: Umbilical artery (not vein) blood is the gold-standard sample for intrapartum acid–base status. Arterial pH < 7.0 with base deficit ≥ 12 = significant metabolic acidosis.

Apgar score — what it is and is NOT

The Apgar score (devised by Virginia Apgar, an anaesthesiologist) is recorded at 1 and 5 minutes, and every 5 minutes thereafter up to 20 minutes if it remains < 7.

Sign 0 1 2
Appearance (colour) Blue/pale Body pink, extremities blue Completely pink
Pulse (heart rate) Absent < 100/min > 100/min
Grimace (reflex irritability) None Grimace Cough/cry/sneeze
Activity (tone) Limp Some flexion Active motion
Respiration Absent Slow/irregular Good cry

High-yield: Apgar is for assessing response to resuscitation, NOT for guiding it — resuscitation begins immediately based on breathing, heart rate and tone, not after waiting for the 1-minute score. A persistently low Apgar at 10–20 min correlates with poor outcome, but the score is a poor stand-alone predictor.

Mnemonic for Apgar components: "How Ready Is This Child?"Heart rate, Respiration, Irritability (reflex), Tone, Colour. (Or simply A-P-G-A-R as above.)


Etiology

Causes are best grouped by timing relative to birth.

Timing Examples
Antepartum (~20%) Maternal hypotension/hypoxia, severe anaemia, pre-eclampsia, IUGR/placental insufficiency, post-term, maternal diabetes
Intrapartum (~70%) Cord prolapse / true knot / nuchal cord, abruptio placentae, uterine rupture, shoulder dystocia, prolonged/obstructed labour, placenta praevia
Postpartum (~10%) Severe cyanotic congenital heart disease, recurrent apnoea, severe pulmonary disease, sepsis/shock

The common final pathway in all is interruption of placental/pulmonary gas exchange → hypoxaemia + hypercarbia + acidosis.


Pathophysiology — the two-phase injury

Understanding the biphasic energy failure explains why hypothermia works and why the 6-hour window exists.

Primary energy failure → acute hypoxia–ischaemia depletes ATP → failure of Na⁺/K⁺-ATPase → cell depolarisation, cytotoxic oedema, glutamate release → excitotoxic Ca²⁺ influx and immediate necrosis.

Then a brief latent phase (≈ 1–6 h) of partial recovery of oxidative metabolism — this is the therapeutic window.

Secondary energy failure (≈ 6–48 h) → mitochondrial dysfunction, oxidative stress, inflammatory cytokines, and apoptosis (delayed/programmed cell death). The severity of secondary failure correlates best with outcome.

Stepwise summary: Asphyxia → ↓ATP & glutamate excitotoxicity (necrosis) → latent phase (window) → mitochondrial failure + apoptosis (secondary injury) → neuronal death.

High-yield: Therapeutic hypothermia works mainly by interrupting the secondary phase — it slows cerebral metabolism, reduces glutamate/free-radical release and inhibits the apoptotic cascade. Hence it must be started before secondary energy failure sets in (within 6 h).

Selective regional vulnerability

The pattern of injury depends on severity and maturity:

  • Acute, profound (total) asphyxia → deep grey matter — basal ganglia, thalamus and brainstem → later dyskinetic CP.
  • Prolonged, partial asphyxiaparasagittal watershed cortical/subcortical white matter → spastic quadriplegia, cognitive deficits.
  • In preterm infants → periventricular leukomalacia (PVL) and germinal matrix/IVH.

The "diving reflex" redistributes blood to brain, heart and adrenals at the expense of gut, kidney, skin and muscle — explaining the multi-organ involvement below.


Clinical features & Sarnat staging

HIE is graded clinically using the Sarnat & Sarnat staging (Stage I/II/III = mild/moderate/severe). This is one of the single most-asked tables in paediatrics.

Feature Stage I (Mild) Stage II (Moderate) Stage III (Severe)
Level of consciousness Hyperalert, irritable Lethargic / obtunded Stupor / coma
Muscle tone Normal Hypotonia Flaccid
Posture Mild distal flexion Strong distal flexion Decerebrate
Tendon reflexes Increased Increased Depressed/absent
Myoclonus Present Present Absent
Moro reflex Strong Weak, incomplete Absent
Suck Active Weak Absent
Pupils Dilated, reactive Constricted Variable/fixed, poor light reflex
Seizures Absent Common (peak ~24 h) Uncommon (or subtle); EEG burst-suppression
Autonomic Sympathetic (tachycardia) Parasympathetic (bradycardia, ↑secretions) Both depressed
EEG Normal Low voltage, periodic, seizures Burst-suppression → isoelectric
Duration / outcome < 24 h, excellent prognosis 2–14 days, variable Hours–weeks, high mortality / severe sequelae

High-yield: Mild (Sarnat I) HIE has a near-normal outcome and does NOT qualify for therapeutic hypothermia. Cooling is indicated only for moderate-to-severe (Sarnat II/III) encephalopathy.

High-yield: Seizures in HIE peak at ~12–24 hours of life, are commonest in moderate (Stage II) HIE, and are frequently subtle (lip-smacking, cycling, eye deviation, apnoea) rather than overt tonic-clonic.


Multi-organ dysfunction (MSOF)

Asphyxia is a multi-system disease; the brain is the most important but rarely the only organ hit. Examiners love the kidney as the most commonly affected organ.

System Manifestation
Renal (most common) Acute tubular necrosis, oliguria, ↑creatinine, SIADH
CNS HIE, seizures, cerebral oedema
Cardiac Myocardial ischaemia, hypotension, tricuspid regurgitation, cardiogenic shock
Pulmonary PPHN, meconium aspiration syndrome, RDS, pulmonary haemorrhage
GI Feed intolerance, necrotising enterocolitis
Haematological DIC, thrombocytopenia
Metabolic Hypoglycaemia, hypocalcaemia, hyponatraemia, metabolic acidosis
Hepatic Transaminitis, coagulopathy

High-yield: The kidney (ATN) is the most frequently involved organ in perinatal asphyxia. Monitor urine output and creatinine. Hypoglycaemia worsens brain injury and must be aggressively corrected.


Diagnosis & investigations

HIE is primarily a clinical diagnosis (encephalopathy + evidence of perinatal insult). Investigations confirm, grade severity and predict outcome.

  1. Cord/early arterial blood gas → pH, base deficit (defines acidosis).
  2. Blood glucose, calcium, electrolytes, RFT, LFT, coagulation → MSOF and correctable factors.
  3. aEEG / continuous EEG → seizure detection + background grading (best bedside predictor; see below).
  4. Cranial ultrasound → bedside, detects oedema, IVH, gross lesions; poor for early cortical injury.
  5. MRI brain (investigation of choice for prognosis) → done at day 4–7 (or up to 2 weeks). Diffusion-weighted imaging (DWI) shows restricted diffusion earliest (24 h–4 days, may pseudonormalise by day 7–10).

High-yield: MRI is the imaging investigation of choice for confirming and prognosticating HIE. Basal ganglia/thalamus and posterior limb of internal capsule (PLIC) involvement predicts the worst neuromotor outcome; an abnormal PLIC signal is a strong predictor of adverse outcome.

aEEG / EEG monitoring

Amplitude-integrated EEG (aEEG) is used both for eligibility screening and prognosis. Background patterns from best to worst:

Continuous normal voltage → discontinuous normal voltage → burst-suppression → continuous low voltage → flat (isoelectric).

High-yield: A burst-suppression, low-voltage or flat (isoelectric) aEEG that fails to recover by 24–48 h carries a poor prognosis. Early recovery of a normal background within 24–36 h is reassuring.


Management

A. Delivery-room resuscitation (NRP)

Follow the Neonatal Resuscitation Programme (NRP) algorithm:

Initial steps (warmth, position, clear airway, dry, stimulate) → if apnoeic/HR < 100 → PPV (the single most important step) → if HR < 100 despite effective ventilation → MR SOPA corrective steps → if HR < 60 after 30 s of effective PPV → chest compressions (3:1 with ventilation) + 100% O₂ → if still HR < 60 → IV adrenaline 0.01–0.03 mg/kg.

High-yield: Effective ventilation (PPV) is the cornerstone of neonatal resuscitation — most asphyxiated newborns respond to ventilation alone. Compressions and adrenaline are needed only in a minority.

High-yield: Start resuscitation of term/near-term infants with room air (21% O₂), titrating to preductal SpO₂ targets, rather than 100% oxygen (hyperoxia is harmful). Reserve higher FiO₂ for compressions or failure to improve.

B. Therapeutic (controlled) hypothermia — the only proven neuroprotectant

High-yield: Cool moderate-to-severe HIE (Sarnat II/III) infants to a core temperature of 33–34 °C for 72 hours, started within 6 hours of birth, followed by slow rewarming (~0.5 °C/hour). Either whole-body cooling or selective head cooling can be used.

Eligibility (typical) criteria — all met:

Domain Requirement
Gestation ≥ 36 weeks (some units ≥ 35) and birth weight ≥ 1800–2000 g
Age < 6 hours of life
Physiological evidence Apgar ≤ 5 at 10 min, OR ongoing resuscitation/PPV at 10 min, OR cord/early pH < 7.0 or base deficit ≥ 16 (≥12 with other criteria)
Neurological Moderate-to-severe encephalopathy clinically and/or abnormal aEEG

Benefit: Major trials (CoolCap, NICHD, TOBY) showed cooling reduces the combined outcome of death or major neurodevelopmental disability; NNT ≈ 7–9. Most effective in moderate HIE.

Contraindications/cautions: preterm < 35–36 weeks, > 6 h of age, major congenital anomaly, severe coagulopathy/bleeding, severe IUGR. Side-effects: sinus bradycardia (expected/benign), thrombocytopenia, subcutaneous fat necrosis, mild coagulopathy, persistent pulmonary hypertension.

C. Supportive care (equally vital)

  • Ventilation/oxygenation: maintain normocapnia (avoid hypocapnia → cerebral vasoconstriction worsens ischaemia) and normoxia (avoid hyperoxia).
  • Circulation: maintain normal BP/perfusion; treat hypotension with volume/inotropes; avoid fluid overload.
  • Glucose: maintain euglycaemia — both hypo- and hyperglycaemia worsen injury.
  • Fluids: mild fluid restriction anticipating SIADH/ATN; monitor urine output, electrolytes.
  • Correct hypocalcaemia, acidosis, coagulopathy.
  • Seizure control (see DOC below).
  • Avoid hyperthermia at all costs — even mild fever worsens outcome.

D. Seizure management — drug of choice

High-yield: Phenobarbitone (phenobarbital) is the first-line drug of choice for neonatal/HIE seizures: loading dose 20 mg/kg IV, may repeat 10 mg/kg up to 40 mg/kg total. Second line: phenytoin/fosphenytoin or levetiracetam; midazolam infusion for refractory seizures.

Correct hypoglycaemia and hypocalcaemia first, as these are reversible causes.


Complications

Acute: refractory seizures, cerebral oedema/raised ICP, SIADH, ATN/renal failure, PPHN, NEC, DIC, cardiogenic shock, death.

Long-term neurodevelopmental:

  • Cerebral palsy — spastic quadriplegic (watershed pattern) or dyskinetic/athetoid (basal ganglia pattern).
  • Cognitive impairment / learning disability.
  • Epilepsy.
  • Sensorineural hearing loss and visual (cortical) impairment.
  • Microcephaly, feeding difficulties.

Predictors of poor neurodevelopmental outcome

Strong adverse predictor Note
Severe (Sarnat III) encephalopathy Highest risk of death/CP
Apgar 0–3 beyond 5–10 min (esp. persisting at 20 min)
Persistent burst-suppression / low-voltage aEEG > 24–48 h
MRI: basal ganglia/thalamus + abnormal PLIC Worst motor outcome
Seizures, especially early and refractory
Failure to establish spontaneous respiration by 20–30 min
Multi-organ failure

Key differentials

HIE is a diagnosis that requires excluding mimics of neonatal encephalopathy:

  • Sepsis / meningitis (GBS, E. coli, HSV) — always rule out; treat empirically if in doubt.
  • Inborn errors of metabolism — urea cycle defects, maple syrup urine disease, non-ketotic hyperglycinaemia (encephalopathy ± acidosis ± hypoglycaemia, often with a symptom-free interval).
  • Metabolic disturbances — hypoglycaemia, hypocalcaemia, hyponatraemia, kernicterus.
  • Intracranial haemorrhage / traumatic birth injury — subdural, IVH.
  • Neonatal stroke (arterial ischaemic) — often presents only with focal seizures in an otherwise well baby.
  • Neuromuscular disorders / congenital myopathies — hypotonia without encephalopathy.
  • Drug effects — maternal opioids/magnesium, neonatal sedatives.

High-yield: A baby with focal seizures but a normal inter-ictal state and no asphyxial history suggests neonatal arterial ischaemic stroke, not global HIE.


Recently asked / exam angle

  • Sarnat staging matched to a clinical vignette (consciousness + tone + reflexes + seizures) — the single most repeated question. Know which stage is eligible for cooling (II/III only).
  • Therapeutic hypothermia numbers: 33–34 °C, 72 hours, within 6 hours, ≥ 36 weeks — direct one-liner MCQs.
  • ACOG criteria / umbilical artery pH < 7.0, base deficit ≥ 12 as the definition of significant intrapartum acidosis.
  • "Most common organ affected in birth asphyxia" → kidney (ATN).
  • MRI (with DWI) as investigation of choice for prognosis; basal ganglia/PLIC = worst outcome.
  • Phenobarbitone 20 mg/kg as first-line anticonvulsant.
  • "Apgar is for assessing response, not for initiating resuscitation"; resuscitation is driven by HR, breathing, tone.
  • Effective PPV as the most important step in neonatal resuscitation; room air for term babies.
  • Trial names: CoolCap, NICHD, TOBY (hypothermia evidence).
  • Seizures peak at 12–24 h and are often subtle.

Rapid revision

  1. Birth asphyxia = hypoxaemia + hypercarbia + metabolic acidosis; HIE = the brain injury that follows.
  2. ACOG significant acidosis = umbilical artery pH < 7.0 + base deficit ≥ 12 mmol/L.
  3. Apgar scored at 1 and 5 min; assesses response, does not guide resuscitation.
  4. Injury is biphasic — primary necrosis → latent window → secondary apoptotic energy failure; hypothermia targets the secondary phase.
  5. Acute total asphyxia → basal ganglia/thalamus (dyskinetic CP); prolonged partial → watershed cortex (spastic quadriplegia); preterm → PVL.
  6. Sarnat I = excellent prognosis & not cooled; II/III = candidates for hypothermia.
  7. Cool to 33–34 °C for 72 h within 6 h of birth in ≥ 36-week infants with moderate-severe HIE.
  8. Most common organ involved = kidney (ATN); watch for SIADH and hypoglycaemia.
  9. Investigation of choice for prognosis = MRI (DWI); abnormal PLIC / basal ganglia = worst motor outcome.
  10. aEEG burst-suppression/flat not recovering by 24–48 h = poor prognosis.
  11. Phenobarbitone 20 mg/kg IV = first-line anticonvulsant; correct glucose & calcium first.
  12. Avoid hyperthermia, hyperoxia, hypocapnia and hypoglycaemia — all worsen the brain injury.